rewirebio.iobenchmarks
Evidence claim

Relevance of Recovery of known expression-outlier genes and outlier calls in true-negative samples, patient RNA-seq (Silverstein et al. Table S9, OUTRIDER) to "Select a patient-RNA splicing-variant validation workflow"

Use case
Select a patient-RNA splicing-variant validation workflow
Assessed by
Recovery of known expression-outlier genes and outlier calls in true-negative samples, patient RNA-seq (Silverstein et al. Table S9, OUTRIDER)
Relevance
Proxy evidence
Endpoint
TP, FN, TN and FP counts with accuracy, precision, recall, F1 and MCC for OUTRIDER with and without 100 GTEx controls

Proxy: expression-outlier recovery of known loss-of-function genes in the same patient RNA-seq, which supports but does not identify splice-altering variants.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

36 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-22-1b7cf027e4f6
Property and statementOriginal source and locationReview and provenance
Citation locations
2 values
  • source id
    rna-splicing-20261011-silverstein2026-source-tables-s1-s10
    locator
    Table S9 rows 7 and 8
  • source id
    rna-splicing-20261011-silverstein2026-source-article
    locator
    Methods 'Expression Tools' and 'True Positive and Negative Detection'; Table S7
Context-only references
Benchmarking RNA-seq Tools for Real-World Diagnostic Applications (Silverstein et al., medRxiv 2026)

Original source ↗

rna-splicing-20261011-silverstein2026-source-tables-s1-s10: Table S9 rows 7 and 8; rna-splicing-20261011-silverstein2026-source-article: Methods 'Expression Tools' and 'True Positive and Negative Detection'; Table S7

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: medRxiv preprint version 1, posted 2026-01-28; JATS source XML
Retrieved: 2026-10-11T21:38:32Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.citation_locators

Source artifact SHA-256: 8b987ac49f086adc0a191522436529a70f243505f7dda9926786004e15b4601c

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Citation locations
2 values
  • source id
    rna-splicing-20261011-silverstein2026-source-tables-s1-s10
    locator
    Table S9 rows 7 and 8
  • source id
    rna-splicing-20261011-silverstein2026-source-article
    locator
    Methods 'Expression Tools' and 'True Positive and Negative Detection'; Table S7
Context-only references
Silverstein et al. 2026 Supplemental Tables S1-S10 (medRxiv media-3.xlsx)

Original source ↗

rna-splicing-20261011-silverstein2026-source-tables-s1-s10: Table S9 rows 7 and 8; rna-splicing-20261011-silverstein2026-source-article: Methods 'Expression Tools' and 'True Positive and Negative Detection'; Table S7

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: medRxiv preprint version 1 supplement DC3 (file 344940_file09.xlsx in the JATS XML)
Retrieved: 2026-10-11T21:38:52Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.citation_locators

Source artifact SHA-256: 3d137444b13225cf1223ad73758fdfcb4b5f772263e0aafd827d8ca57ca00120

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison group
silverstein2026-neuromuscular
Context-only references
Benchmarking RNA-seq Tools for Real-World Diagnostic Applications (Silverstein et al., medRxiv 2026)

Original source ↗

rna-splicing-20261011-silverstein2026-source-tables-s1-s10: Table S9 rows 7 and 8; rna-splicing-20261011-silverstein2026-source-article: Methods 'Expression Tools' and 'True Positive and Negative Detection'; Table S7

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: medRxiv preprint version 1, posted 2026-01-28; JATS source XML
Retrieved: 2026-10-11T21:38:32Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.comparison_group

Source artifact SHA-256: 8b987ac49f086adc0a191522436529a70f243505f7dda9926786004e15b4601c

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison group
silverstein2026-neuromuscular
Context-only references
Silverstein et al. 2026 Supplemental Tables S1-S10 (medRxiv media-3.xlsx)

Original source ↗

rna-splicing-20261011-silverstein2026-source-tables-s1-s10: Table S9 rows 7 and 8; rna-splicing-20261011-silverstein2026-source-article: Methods 'Expression Tools' and 'True Positive and Negative Detection'; Table S7

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: medRxiv preprint version 1 supplement DC3 (file 344940_file09.xlsx in the JATS XML)
Retrieved: 2026-10-11T21:38:52Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.comparison_group

Source artifact SHA-256: 3d137444b13225cf1223ad73758fdfcb4b5f772263e0aafd827d8ca57ca00120

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison title
RNA-seq tools on known diagnoses and true-negative samples, neuromuscular patient RNA-seq (Silverstein et al. 2026)
Context-only references
Benchmarking RNA-seq Tools for Real-World Diagnostic Applications (Silverstein et al., medRxiv 2026)

Original source ↗

rna-splicing-20261011-silverstein2026-source-tables-s1-s10: Table S9 rows 7 and 8; rna-splicing-20261011-silverstein2026-source-article: Methods 'Expression Tools' and 'True Positive and Negative Detection'; Table S7

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: medRxiv preprint version 1, posted 2026-01-28; JATS source XML
Retrieved: 2026-10-11T21:38:32Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.comparison_title

Source artifact SHA-256: 8b987ac49f086adc0a191522436529a70f243505f7dda9926786004e15b4601c

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison title
RNA-seq tools on known diagnoses and true-negative samples, neuromuscular patient RNA-seq (Silverstein et al. 2026)
Context-only references
Silverstein et al. 2026 Supplemental Tables S1-S10 (medRxiv media-3.xlsx)

Original source ↗

rna-splicing-20261011-silverstein2026-source-tables-s1-s10: Table S9 rows 7 and 8; rna-splicing-20261011-silverstein2026-source-article: Methods 'Expression Tools' and 'True Positive and Negative Detection'; Table S7

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: medRxiv preprint version 1 supplement DC3 (file 344940_file09.xlsx in the JATS XML)
Retrieved: 2026-10-11T21:38:52Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.comparison_title

Source artifact SHA-256: 3d137444b13225cf1223ad73758fdfcb4b5f772263e0aafd827d8ca57ca00120

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Constraints
3 values
  • Inspect every linked evaluation's source locator and population before citing a result.
  • Do not combine this mapping's evaluations with any other protocol's results; truth sets, inputs and metrics differ between sources.
  • Compare tools only where their populations match; Table S9 denominators differ by tool.
Context-only references
Benchmarking RNA-seq Tools for Real-World Diagnostic Applications (Silverstein et al., medRxiv 2026)

Original source ↗

rna-splicing-20261011-silverstein2026-source-tables-s1-s10: Table S9 rows 7 and 8; rna-splicing-20261011-silverstein2026-source-article: Methods 'Expression Tools' and 'True Positive and Negative Detection'; Table S7

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: medRxiv preprint version 1, posted 2026-01-28; JATS source XML
Retrieved: 2026-10-11T21:38:32Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.constraints

Source artifact SHA-256: 8b987ac49f086adc0a191522436529a70f243505f7dda9926786004e15b4601c

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Constraints
3 values
  • Inspect every linked evaluation's source locator and population before citing a result.
  • Do not combine this mapping's evaluations with any other protocol's results; truth sets, inputs and metrics differ between sources.
  • Compare tools only where their populations match; Table S9 denominators differ by tool.
Context-only references
Silverstein et al. 2026 Supplemental Tables S1-S10 (medRxiv media-3.xlsx)

Original source ↗

rna-splicing-20261011-silverstein2026-source-tables-s1-s10: Table S9 rows 7 and 8; rna-splicing-20261011-silverstein2026-source-article: Methods 'Expression Tools' and 'True Positive and Negative Detection'; Table S7

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: medRxiv preprint version 1 supplement DC3 (file 344940_file09.xlsx in the JATS XML)
Retrieved: 2026-10-11T21:38:52Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.constraints

Source artifact SHA-256: 3d137444b13225cf1223ad73758fdfcb4b5f772263e0aafd827d8ca57ca00120

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Endpoint
TP, FN, TN and FP counts with accuracy, precision, recall, F1 and MCC for OUTRIDER with and without 100 GTEx controls
Context-only references
Benchmarking RNA-seq Tools for Real-World Diagnostic Applications (Silverstein et al., medRxiv 2026)

Original source ↗

rna-splicing-20261011-silverstein2026-source-tables-s1-s10: Table S9 rows 7 and 8; rna-splicing-20261011-silverstein2026-source-article: Methods 'Expression Tools' and 'True Positive and Negative Detection'; Table S7

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: medRxiv preprint version 1, posted 2026-01-28; JATS source XML
Retrieved: 2026-10-11T21:38:32Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.endpoint

Source artifact SHA-256: 8b987ac49f086adc0a191522436529a70f243505f7dda9926786004e15b4601c

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Endpoint
TP, FN, TN and FP counts with accuracy, precision, recall, F1 and MCC for OUTRIDER with and without 100 GTEx controls
Context-only references
Silverstein et al. 2026 Supplemental Tables S1-S10 (medRxiv media-3.xlsx)

Original source ↗

rna-splicing-20261011-silverstein2026-source-tables-s1-s10: Table S9 rows 7 and 8; rna-splicing-20261011-silverstein2026-source-article: Methods 'Expression Tools' and 'True Positive and Negative Detection'; Table S7

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: medRxiv preprint version 1 supplement DC3 (file 344940_file09.xlsx in the JATS XML)
Retrieved: 2026-10-11T21:38:52Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.endpoint

Source artifact SHA-256: 3d137444b13225cf1223ad73758fdfcb4b5f772263e0aafd827d8ca57ca00120

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-10-22-1b7cf027e4f6 · Record review: needs review

2 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: use-case-mapping-rna-splicing-20261011-silverstein2026-expression

field
links:assessed_by:rna-splicing-20261011-silverstein2026-protocol-expression
value
rna-splicing-20261011-silverstein2026-protocol-expression
relevance
proxy
endpoint
TP, FN, TN and FP counts with accuracy, precision, recall, F1 and MCC for OUTRIDER with and without 100 GTEx controls
rationale
Proxy: expression-outlier recovery of known loss-of-function genes in the same patient RNA-seq, which supports but does not identify splice-altering variants.
constraints
Inspect every linked evaluation's source locator and population before citing a result.; Do not combine this mapping's evaluations with any other protocol's results; truth sets, inputs and metrics differ between sources.; Compare tools only where their populations match; Table S9 denominators differ by tool.
limitations
OUTRIDER + GTEx was run on muscle only (14 positives); OUTRIDER on muscle and fibroblast (15 positives).; The authors did not develop rMATS-turbo, MINTIE, FRASER, LeafcutterMD, OUTRIDER or the DROP MAE module. ANEVA-h is the authors' own method: two of its authors (K. R. Ganapathy and S. Silverstein) are the first and third authors of reference 36, the ANEVA-h preprint, so the ANEVA-H row is recorded as author_reported.; Positives are counted per known event or gene, negatives per true-negative sample: a negative sample with any reported outlier counts as one false positive. Accuracy, precision and MCC therefore mix event-level and sample-level units (Methods 'True Positive and Negative Detection').; Variants with clinically interpretable mechanisms were selected; the authors state this favours clearly defined events and likely underestimates tool sensitivity, and that binary outlier scoring of negatives may overestimate false-positive rates and lowers MCC (Discussion, limitations paragraph).; Retrospective study of a single centre's neuromuscular cohort; no confidence intervals are printed.; Preprint (medRxiv v1), not peer reviewed.; Table S7 true-negative rows do not reproduce Table S9 rows 7 and 8: read as in Tables S3, S4 and S8 ('YES' = no outlier), Table S7 gives OUTRIDER 8 of 9 negative samples without outliers (Table S9: 4) and OUTRIDER + GTEx 1 of 6 (Table S9: 1 of 5). The prose rates (56% and 83%) match Table S9 for OUTRIDER and Table S7 for OUTRIDER + GTEx.
citation locators
source id: rna-splicing-20261011-silverstein2026-source-tables-s1-s10; locator: Table S9 rows 7 and 8; source id: rna-splicing-20261011-silverstein2026-source-article; locator: Methods 'Expression Tools' and 'True Positive and Negative Detection'; Table S7
source locator
rna-splicing-20261011-silverstein2026-source-tables-s1-s10: Table S9 rows 7 and 8; rna-splicing-20261011-silverstein2026-source-article: Methods 'Expression Tools' and 'True Positive and Negative Detection'; Table S7
headline metric
recall
comparison group
silverstein2026-neuromuscular
comparison title
RNA-seq tools on known diagnoses and true-negative samples, neuromuscular patient RNA-seq (Silverstein et al. 2026)
stratum label
Expression-outlier caller
stratum order
2
reason
Not shown: Table S7 true-negative rows conflict with Table S9 rows 7 and 8 for OUTRIDER and OUTRIDER + GTEx. Kept at needs_review by the independent review (docs/reviews/use-cases/splicing-cnv-use-cases-2026-10-12.md).
Related records

Suggest a correction